Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133365) titled 'Multimodal Identification of Metastatic Pancreatic Cancer' on Sept. 24.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Pancreatic ductal adenocarcinoma (PDAC) Pancreatic metastatic carcinoma (PMET) Focal autoimmune pancreatitis (FAIP
Intervention:
Pancreatic Lymphoma Group:None
Solid Pseudopapillary Tumor Group:None
Pancreatic Metastatic Carcinoma Group:None
Chronic Pancreatitis Group:None
Focal Autoimmune Pancreatitis Group:None
Pancreatic Cancer Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrol...